Karin E. M. Diderich

Karin E. M. Diderich

Auto-generated profile, based on publicly available information

Karin E. M. Diderich

Department of Clinical Genetics Erasmus MC University Medical Center Rotterdam The Netherlands

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in Molecular Cytogenetics
Verified
Journal Article
Open access
PDF file
MSMalgorzata I Srebniak
Malgorzata I Srebniak
MBMarjan Boter
Marjan Boter
GOGretel O Oudesluijs
Gretel O Oudesluijs
TCTitia Cohen-Overbeek
Titia Cohen-Overbeek
LGLutgarde Cp Govaerts
Lutgarde Cp Govaerts
RGRobert-Jan H Galjaard
Robert-Jan H Galjaard
We have investigated whether replacing conventional karyotyping by SNP array analysis in cases of foetal ultrasound abnormalities would increase the diagnostic yield and speed of prenatal diagnosis in clinical practice.

29 November 2020 in Acta Obstetricia et Gynecologica Scandinavica
Verified
Journal Article
Open access
PDF file
KDKarin E. M. Diderich
Karin E. M. Diderich
KRKathleen Romijn
Kathleen Romijn
MJMarieke Joosten
Marieke Joosten
LGLutgarde C. P. Govaerts
Lutgarde C. P. Govaerts
MPMarike Polak
Marike Polak
MSMalgorzata I. Srebniak
Malgorzata I. Srebniak
Introduction: The aim of this retrospective cohort study was to determine the potential diagnostic yield of prenatal whole exome sequencing in fetuses with structural anomalies on expert ultrasound scans and normal chromosomal microarray results.Material and methods: In the period 2013‐2016, 391 pregnant women with fetal ultrasound anomalies who received normal chromosomal microarray results, were referred for additional genetic counseling and opted for additional molecular testing pre‐ and/or postnatally. Most of the couples received only a targeted molecular test and in 159 cases (40.7%) whole exome sequencing (broad gene panels or open exome) was performed. The results of these molecular tests were evaluated retrospectively, regardless of the time of the genetic diagnosis (prenatal or postnatal).Results: In 76 of 391 fetuses (19.4%, 95% CI 15.8%‐23.6%) molecular testing provided a genetic diagnosis with identification of (likely) pathogenic variants. In the majority of cases (91.1%, 73/76) the (likely) pathogenic variant would be detected by prenatal whole exome sequencing analysis.Conclusions: Our retrospective cohort study shows that prenatal whole exome sequencing, if offered by a clinical geneticist, in addition to chromosomal microarray, would notably increase the diagnostic yield in fetuses with ultrasound anomalies and would allow early diagnosis of a genetic disorder irrespective of the (incomplete) fetal phenotype.

1 November 2024 in Science
Verified
Journal Article
Closed access
FKFlorian Kraft
Florian Kraft
PRPiere Rodriguez-Aliaga
Piere Rodriguez-Aliaga
WYWeimin Yuan
Weimin Yuan
LFLena Franken
Lena Franken
KZKamil Zajt
Kamil Zajt
IKIngo Kurth
Ingo Kurth
Malformations of the brain are common and vary in severity, from negligible to potentially fatal. Their causes have not been fully elucidated. Here, we report pathogenic variants in the core protein-folding machinery TRiC/CCT in individuals with brain malformations, intellectual disability, and seizures. The chaperonin TRiC is an obligate hetero-oligomer, and we identify variants in seven of its eight subunits, all of which impair function or assembly through different mechanisms. Transcriptome and proteome analyses of patient-derived fibroblasts demonstrate the various consequences of TRiC impairment. The results reveal an unexpected and potentially widespread role for protein folding in the development of the central nervous system and define a disease spectrum of “TRiCopathies.”

7 July 2020 in Journal of Genetic Counseling
Verified
Journal Article
Open access
PDF file
JHJennifer Hammond
Jennifer Hammond
JKJasmijn E. Klapwijk
Jasmijn E. Klapwijk
MHMelissa Hill
Melissa Hill
SLStina Lou
Stina Lou
KOKelly Ormond
Kelly Ormond
CLCeline Lewis
Celine Lewis
For a number of prospective parents, uncertainty during pregnancy starts when an anomaly is found during a routine fetal anomaly scan. This may be followed by numerous tests to determine the etiology and nature of the anomaly. In this study, we aimed to understand how prospective parents perceive and manage uncertainty after being confronted with a structural anomaly during their routine ultrasound. Han's taxonomy of uncertainty was used as a framework to identify and understand the different types of uncertainty experienced. Interviews were held in the UK (n = 8 women and n = 1 male partner) and in the Netherlands (n = 7 women) with participants who had experienced uncertainty in their pregnancy after a fetal scan. Data were analyzed using thematic analysis, and the uncertainties experienced by parents were mapped against the dimensions of the Han taxonomy (sources, issues, and locus). Participants' experience of uncertainty was relevant to all dimensions and subcategories of the Han taxonomy, showing its applicability in the prenatal setting. Sources of uncertainty included receiving probabilistic or ambiguous information about the anomaly, or information that was complex and challenging to understand. Issues of uncertainty included were those that were scientific—such as a probable diagnosis with no further information, personal—such as the emotional impact of uncertainty, and practical—such as limited information about medical procedures and practical aspects of care. Additionally, participants described what helped them to manage uncertainty. This included active coping strategies such as searching for information on the Internet, external coping resources such as seeking social support, and internal coping resources such as using positivity and hope. Several recommendations for the healthcare professional to minimize uncertainty and help the patient deal with uncertainty have been proposed based on these findings.

7 September 2016 in Molecular Cytogenetics
Verified
Journal Article
Open access
PDF file
MSMalgorzata I. Srebniak
Malgorzata I. Srebniak
MWMerel C. de Wit
Merel C. de Wit
KDKarin E. M. Diderich
Karin E. M. Diderich
LGLutgarde C. P. Govaerts
Lutgarde C. P. Govaerts
MJMarieke Joosten
Marieke Joosten
DODiane Van Opstal
Diane Van Opstal
Since non-invasive prenatal testing (NIPT) in maternal blood became available, we evaluated which chromosome aberrations found in our cohort of fetuses with an enlarged NT in the first trimester of pregnancy (tested with SNP microarray) could be detected by NIPT as well. 362 fetuses were referred for cytogenetic testing due to an enlarged NT (≥3.5 mm). Chromosome aberrations were investigated using QF-PCR, karyotyping and whole genome SNP array. After invasive testing a chromosomal abnormality was detected in 137/362 (38 %) fetuses. 100/362 (28 %) cases concerned trisomy 21, 18 or 13, 25/362 (7 %) an aneuploidy of sex chromosomes and 3/362 (0.8 %) triploidy. In 6/362 (1.6 %) a pathogenic structural unbalanced chromosome aberration was seen and in 3/362 (0.8 %) a susceptibility locus for neurodevelopmental disorders was found. We estimated that in 2–10 % of fetuses with enlarged NT a chromosome aberration would be missed by current NIPT approaches. Based on our cohort of fetuses with enlarged NT we may conclude that NIPT, depending on the approach, will miss chromosome aberrations in a significant percentage of pregnancies. Moreover all abnormal NIPT results require confirmatory studies with invasive testing, which will delay definitive diagnosis in ca. 30 % of patients. These figures are important for pretest counseling enabling pregnant women to make informed choices on the prenatal test. Larger cohorts of fetuses with an enlarged NT should be investigated to assess the additional diagnostic value of high resolution array testing for this indication.

11 June 2024 in Clinical Genetics
Verified
Journal Article
Open access
RSRachel Schot
Rachel Schot
FFFederico Ferraro
Federico Ferraro
GGGeert Geeven
Geert Geeven
KDKarin E. M. Diderich
Karin E. M. Diderich
TBTahsin Stefan Barakat
Tahsin Stefan Barakat
Despite increasing knowledge of disease‐causing genes in human genetics, approximately half of the individuals affected by neurodevelopmental disorders remain genetically undiagnosed. Part of this missing heritability might be caused by genetic variants outside of protein‐coding genes, which are not routinely diagnostically investigated. A recent preprint identified de novo variants in the non‐coding spliceosomal snRNA gene RNU4‐2 as a cause of a frequent novel syndromic neurodevelopmental disorder. Here we mined 164 whole genome sequencing (WGS) trios from individuals with neurodevelopmental or multiple congenital anomaly disorders that received diagnostic genomic investigations at our clinic. We identify a recurrent de novo RNU4‐2 variant (NR_003137.2(RNU4‐2):n.64_65insT) in a 5‐year‐old girl with severe global developmental delay, hypotonia, microcephaly, and seizures that likely explains her phenotype, given that extensive previous genetic investigations failed to identify an alternative cause. We present detailed phenotyping of the individual obtained during a 5‐year follow‐up. This includes photographs showing recognizable facial features for this novel disorder, which might allow prioritizing other currently unexplained affected individuals sharing similar facial features for targeted investigations of RNU4‐2. This case illustrates the power of re‐analysis to solve previously unexplained cases even when a diagnostic genome remains negative.